PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Genedata

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Genedata Strengthens TcLand Expression’s Research Informatics Infrastructure - Genedata strengthens TcLand Expression’s Research Informatics Infrastructure for pioneering work in personalized medicine
Genedata Strengthens TcLand Expression’s Research Informatics Infrastructure

 

NewswireToday - /newswire/ - Basel, Switzerland, 2009/03/24 - Genedata strengthens TcLand Expression’s Research Informatics Infrastructure for pioneering work in personalized medicine.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Genedata, a leading provider of in-silico solutions for pharmaceutical R&D and related life sciences, today announced a collaboration with TcLand Expression, a world-leading company in the field of gene expression biomarkers for autoimmune disorders and transplantation. As part of the collaboration, the Genedata Phylosopher® and Expressionist® biomarker discovery platforms will be integrated into TcLand Expression’s computational infrastructure.

TcLand Expression is pioneering work in the field of personalized medicine for transplantation and autoimmune diseases. The company is developing gene expression signatures in collaboration with health care professionals and patients worldwide. The Genedata Expressionist® and Phylosopher® platforms will serve as a scalable core infrastructure supporting interdisciplinary biomarker identification, validation and mode-of-action studies. The platform will enable TcLand Expression’s researchers to take a cross-technology approach by using automated workflows and integrated analysis tools to streamline the research workflow, from experimental design through to final results.

“Genedata’s biomarker platform complements perfectly our existing clinical and sample management systems,” commented Alessandra Cervino DPhil, VP Biostatistics and Bioinformatics at TcLand Expression. “Genedata’s integrated solution combines the flexibility needed in our R&D processes with the automation, traceability and 21 CFR part 11 compliance needed in our clinical studies.”

“Genedata’s integrated solution fits in well with TcLand Expression’s quality commitment to our R&D,” stated Alain Huriez MD, Chairman and CEO of TcLand Expression.

"We are delighted that TcLand Expression, one of the innovators in the area of personalized medicine, has chosen our platform to address their computational requirements,” said Othmar Pfannes, CEO of Genedata. “This collaboration validates our strategy of delivering scalable and flexible research IT infrastructure solutions for biomarker discovery, monitoring and biological interpretation.”

About TcLand Expression
TcLand Expression (tcland-expression.com) is a recognized pioneer in the discovery and development of gene expression biomarkers for unmet medical needs in transplantation and auto-immune diseases. The company benefits from an exceptional scientific environment and is focusing on two major therapeutic areas with huge remaining unmet needs: transplantation and auto-immune diseases.

About Genedata
Genedata (genedata.com) develops and globally markets sophisticated computational solutions for drug discovery and related research processes in the life sciences. Genedata’s solutions enable scientists to process, integrate, analyze, and manage large and complex experimental data sets generated by high throughput technologies. Solutions include Genedata Phylosopher® for target discovery and integrative biological data management, Genedata Screener® for automated high throughput screening and high content screening, and Genedata Expressionist® for biomarker discovery and personalized medicine. Founded in 1997, Genedata is privately held, with headquarters in Basel, Switzerland, and offices in Boston and San Francisco, USA, Konstanz and Munich, Germany and Tokyo, Japan.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Genedata

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Genedata Strengthens TcLand Expression’s Research Informatics Infrastructure

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Allison Kurz - Genedata.com 
+41 61 511 8459 communications[.]genedata.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Genedata securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Genedata / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Deb Sheppard - Medium Psychic Author Speaker

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)